Search
Takeda Pharmaceutical Co Ltd
TAKAdd to Watchlist
15.630USD
+0.200+1.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
48.68BMarket Cap
40.75P/E TTM
Risk Assessment
Currency: USD Updated: 2026-06-18The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Pharmaceuticals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Takeda Pharmaceutical Co Ltd is 9.88, ranking 3 out of 157 in the Pharmaceuticals industry. The company's beta value is -0.04. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
-0.04
VaR
+1.96%
240-Day Maximum Drawdown
+20.05%
240-Day Volatility
+20.94%
Return
Best Daily Return
60 days
+2.79%
120 days
+2.96%
5 years
+4.69%
Worst Daily Return
60 days
-4.82%
120 days
-4.82%
5 years
-11.01%
Sharpe Ratio
60 days
-2.39
120 days
+0.21
5 years
+0.01
Risk Assessment
Maximum Drawdown
240 days
+20.05%
3 years
+22.79%
5 years
+27.87%
Return-to-Drawdown Ratio
240 days
+0.19
3 years
+0.04
5 years
-0.06
Skewness
240 days
-0.48
3 years
-0.74
5 years
-0.98
Volatility
Realised Volatility
240 days
+20.94%
5 years
+19.32%
Standardised True Range
240 days
+1.62%
5 years
+1.40%
Downside Risk-Adjusted Return
120 days
+31.83%
240 days
+31.83%
Maximum Daily Upside Volatility
60 days
+19.76%
Maximum Daily Downside Volatility
60 days
+20.82%
Liquidity
Average Turnover Rate
60 days
+0.20%
120 days
+0.19%
5 years
--
Turnover Deviation
20 days
+17.94%
60 days
+19.83%
120 days
+15.50%
